The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
360 - 400 jobs Number of planned job losses
Announcement Date
30 November 2018
Employment effect (start)
1 December 2018
Foreseen end date
31 December 2022
Description
German multinational producer of pharmaceutical and chemical products Merck has announced plans to cut 400 jobs at its headquarters in Darmstadt. The company will shift from the production of liquid crystals into the production of semiconductors and electronic technologies instead. The move is due to increasing price competition by Asian competitors, according to a spokesperson for Merck. Direct dismissals will be avoided, as the company is negotiating a social plan with the works council and the trade union IG BCE. The positions are expected to be cut by the end of 2022.
Sources
Citation
Eurofound (2018), Merck, Internal restructuring in Germany, factsheet number 96168, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/96168.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
